Endocrine Pharmacology

Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells

Article metrics



To investigate whether the prophylactic local delivery of mobilized peripheral blood mononuclear cells (M-PBMNC) could prevent peripheral microangiopathy in diabetic nude mice.


Diabetic nude mice were induced with intraperitoneal injections of streptozotocin. With the time course of diabetes, we detected the capillary and arteriole density of mice adductor muscles by immuno-histopathy. In situ apoptosis was detected by using TdT-mediated dUTP nick end labeling (TUNEL) methods. M-PBMNC were labeled and locally delivered to the adductor muscles. Mononuclear cells were also isolated and cultured in vitro for the detection and counting of endothelial progenitor cells(EPC).


Rarefication of capillaries and arterioles, enhanced apoptosis in adductor muscles, and reduced circulating EPC in diabetic nude mice. Prophylactic local delivery of M-PBMNC halted the progression of microvascular rarefaction in hind-limb skeletal muscles by inhibiting apoptosis. We detected the survival, migration and incorporation of transplanted M-PBMNC into the murine vasculature in vivo. In addition, more EPC were available from M-PBMNC than non-mobilized cells.


These results suggested that the prophylactic local delivery of M-PBMNC may represent a novel approach for the treatment of microvascular complications in diabetics.


  1. 1

    Kannel WB, McGee DL . Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035–8.

  2. 2

    Eckardt A, Kraus O, Kustner E, Neufang A, Schmiedt W, Meurer A, et al. Interdisciplinary treatment of diabetic foot syndrome. Orthopade 2003; 32: 190–8.

  3. 3

    Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG . Aden-ovirus-mediated gene transfer of VEGF (121) improves lower-extremity endothelial function and flow reserve. Circulation 2001; 104: 753–5.

  4. 4

    Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002; 105: 788–93.

  5. 5

    Cao Y, Hong A, Schulten H, Post MJ . Update on therapeutic neovascularization. Cardiovasc Res 2005; 65: 639–48.

  6. 6

    Carmeliet P, Luttun A . The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis. Thromb Haemost 2001; 86: 289–97.

  7. 7

    Henry TD, Abraham JA . Review of preclinical and clinical results with vascular endothelial growth factors for therapeutic angiogenesis. Curr Interv Cardiol Rep 2000 2: 228–41.

  8. 8

    Emanueli C, Graiani G, Salis MB, Gadau S, Desortes E, Madeddu P . Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. Diabetes 2004; 53: 1096–103.

  9. 9

    Emanueli C, Graiani G, Salis MB, Gadau S, Desortes E, Madeddu P . Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation 2002; 106: 993–9.

  10. 10

    Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–7.

  11. 11

    Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422–7.

  12. 12

    Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195–9.

  13. 13

    Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781–6.

  14. 14

    Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC . Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005; 28: 2155–60.

  15. 15

    Kugler CF, Rudofsky G . The challenges of treating peripheral arterial disease. Vasc Med 2000; 8: 109–14.

  16. 16

    Williams DT, Harding KG, Price P . An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care 2005; 28: 2206–10.

  17. 17

    Yang C, Zhang ZH, Li ZJ, Yang RC, Qian GQ, Han ZC . Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb Haemost 2004; 91: 1202–12.

  18. 18

    Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527–36.

  19. 19

    Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221–8.

  20. 20

    Huang PP, Li SZ, Han MZ, Xiao ZJ, Yang RC, Qiu LG, et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis oblit-erans of lower extremities. Thromb Haemost 2004; 91: 606–9.

  21. 21

    Pecora AL, Lazarus HM, Jennis AA, Preti RA, Goldberg SL, Rowley SD, et al. Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance. Biol Blood Marrow Transplant 2002; 8: 536–43.

  22. 22

    Korbling M, Anderlini P . Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood 2001; 98: 2900–8.

  23. 23

    Jansen J, Hanks S, Thompson JM, Dugan MJ, Akard LP . Transplantation of hematopoietic stem cells from the peripheral blood. J Cell Mol Med 2005; 9: 37–50.

  24. 24

    Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA . Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106: 571–8.

  25. 25

    Lee IG, Chae SL, Kim JC . Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye 2006; 20: 546–52.

  26. 26

    Zhou B, Bi YY, Han ZB, Ren H, Fang ZH, Yu XF, et al. G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability. J Thromb Haemost 2006; 4: 993–1002.

  27. 27

    Zhou B, Huang PP, Han ZC . Autologous transplantation of granulocyte colony-stimulating factor mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Response to Fadini and Avogaro. Diabetes Care 2006; 29: 479–80.

  28. 28

    Li S, Zhou B, Han ZC . Therapeutic neovascularization by trans- plantation of mobilized peripheral blood mononuclear cells for limb ischemia: a comparison between CD34+ and CD34-mononuclear cells. Thromb Haemost 2006; 95: 301–11.

  29. 29

    Schiekofer S, Galasso G, Sato K, Kraus BJ, Walsh K . Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol. 2005; 25: 1603–9.

  30. 30

    Tanii M, Yonemitsu Y, Fujii T, Shikada Y, Kohno R, Onimaru M, et al. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res 2006; 98: 55–62.

Download references

Author information

Correspondence to Zhong-chao Han.

Additional information

Project supported by grants of 863 (No 2003AA205060), National Major Grants for Basic Research (No 001CB5101) from the Ministry of Science and Technology of China.

Rights and permissions

Reprints and Permissions

About this article


  • prevention
  • diabetic angiopathis
  • transplantation
  • endothelial cells
  • stem cells

Further reading